Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 4:14 pm Purchase | 2024-12-31 | 13G | INSTIL BIO INC TIL | BML Investment Partners, L.P. | 440,000 6.700% | 93,810![]() (+27.10%) | Filing History |
| 2025-02-13 3:56 pm Sale | 2024-12-31 | 13G | CLIMB BIO, INC. CLYM | BML Investment Partners, L.P. | 0 0.000% | -2,350,682![]() (Position Closed) | Filing History |
| 2025-02-13 3:25 pm Purchase | 2024-12-31 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners, L.P. | 2,373,404 11.400% | 167,058![]() (+7.57%) | Filing History |
| 2025-02-13 3:10 pm Sale | 2024-12-31 | 13G | TECTONIC THERAPEUTIC INC TECX | BML Investment Partners, L.P. | 0 0.000% | -430,688![]() (Position Closed) | Filing History |
| 2025-02-13 2:26 pm Purchase | 2024-12-31 | 13G | ACLARIS THERAPEUTICS INC ACRS | BML Investment Partners, L.P. | 14,250,000 13.300% | 4,854,066![]() (+51.66%) | Filing History |
| 2025-02-04 11:11 am Unchanged | 2025-02-03 | 13D | WHITEHAWK THERAPEUTICS, INC. C WHWK | BML Investment Partners, L.P. | 2,435,000 9.900% | 0 (Unchanged) | Filing History |
| 2025-01-30 3:32 pm Unchanged | 2025-01-30 | 13D | WHITEHAWK THERAPEUTICS, INC. C WHWK | BML Investment Partners, L.P. | 2,435,000 9.900% | 0 (Unchanged) | Filing History |
| 2024-12-31 3:44 pm Purchase | 2024-12-23 | 13G | IKENA ONCOLOGY INC IKNA | BML Investment Partners, L.P. | 303,822 7.600% | 303,822![]() (New Position) | Filing History |
| 2024-12-31 11:13 am Purchase | 2024-12-31 | 13D | WHITEHAWK THERAPEUTICS, INC. C WHWK | BML Investment Partners, L.P. | 2,435,000 9.900% | 1,051,183![]() (+75.96%) | Filing History |
| 2024-12-16 09:50 am Purchase | 2024-12-13 | 13D | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners, L.P. | 7,216,312 8.500% | 1,614,233![]() (+28.81%) | Filing History |
| 2024-12-12 12:29 pm Purchase | 2024-12-06 | 13G | PMV PHARMACEUTICALS INC PMVP | BML Investment Partners, L.P. | 3,269,907 6.300% | 3,269,907![]() (New Position) | Filing History |
| 2024-11-07 1:15 pm Purchase | 2024-11-01 | 13G | ATHIRA PHARMA INC ATHA | BML Investment Partners, L.P. | 248,445 6.500% | 248,445![]() (New Position) | Filing History |
| 2024-11-07 12:50 pm Purchase | 2024-11-01 | 13G | ESSA PHARMA INC EPIX | BML Investment Partners, L.P. | 4,183,223 9.400% | 4,183,223![]() (New Position) | Filing History |
| 2024-10-09 11:40 am Purchase | 2024-10-09 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | BML Investment Partners, L.P. | 447,815 3.500% | 78,519![]() (+21.26%) | Filing History |
| 2024-09-25 7:14 pm Purchase | 2024-09-19 | 13G | ACHILLES THERAPEUTICS PLC ACHL | BML Investment Partners, L.P. | 4,100,002 9.970% | 4,100,002![]() (New Position) | Filing History |
| 2024-09-16 4:42 pm Purchase | 2024-09-10 | 13G | ORAMED PHARMACEUTICALS INC. NE ORMP | BML Investment Partners, L.P. | 2,048,634 5.000% | 2,048,634![]() (New Position) | Filing History |
| 2024-08-28 4:42 pm Purchase | 2024-08-28 | 13G | WHITEHAWK THERAPEUTICS, INC. C WHWK | BML Investment Partners, L.P. | 1,383,817 5.600% | 1,243,154![]() (+883.78%) | Filing History |
| 2024-08-14 9:23 pm Purchase | 2024-08-14 | 13G | TALIS BIOMEDICAL CORP COM TLIS | BML Investment Partners, L.P. | 203,569 11.200% | 69,484![]() (+51.82%) | Filing History |
| 2024-08-14 9:00 pm Purchase | 2024-08-14 | 13G | AN2 THERAPEUTICS INC ANTX | BML Investment Partners, L.P. | 5,749,432 19.300% | 1,500,000![]() (+35.30%) | Filing History |
| 2024-08-14 8:44 pm Purchase | 2024-08-07 | 13G | TALIS BIOMEDICAL CORP COM TLIS | BML Investment Partners, L.P. | 134,085 7.400% | 134,085![]() (New Position) | Filing History |

